News

Filter

Current filters:

VivalisPharmaceutical

Sanofi Pasteur and Vivalis extend MAb accord

19-01-2012

French biopharma company Vivalis (NYSE Euronext: VLS) says it has extended the agreement signed in 2010…

Antibiotics and Infectious diseasesLicensingPharmaceuticalResearchSanofiSanofi PasteurVivalis

Vivalis acquires single-cell antibody from SC World

28-04-2011

French drug firm Vivalis (Euronext: VLS) says it has acquired high-throughput screening (HTS) single-cell…

Asia-PacificLicensingPharmaceuticalSC WorldVivalis

Kaketsuken initiates second trial of flu vaccine using Vivalis EB66 cell line

26-04-2011

Japan’s Chemo-Sero-Therapeutic Research Institute (Kaketsuken) has initiated the first human injection…

GlaxoSmithKlineKaketsukenPharmaceuticalResearchRespiratory and PulmonaryVaccinesVivalis

Vivalis grants rights to EB66 cell line for human vaccine to unnamed company

15-04-2011

France-based biopharma company Vivalis (Euronext: VLS) says that it has signed a research agreement with…

LicensingPharmaceuticalVaccinesVivalis

Back to top